Clinical Trial Update: Clinical Study of Genakumab for Injection in Patients With Acute Gout [Phase 1, Phase 2]

View source ↗

Summary

The document reports a completed Phase 1/Phase 2 clinical study of Genakumab for injection in patients with acute gout, conducted by Changchun GeneScience Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Genakumab

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Acute Gout | Phase 1, Phase 2 | Status: COMPLETED